Developmental regulation of the dopamine D1 receptor in human caudate and putamen

Neuropsychopharmacology

Volumn 21, Issue 5, 1999, Pages 641-649

  Montague, Deidra M ^a   Lawler, Cindy P ^a   Mailman, Richard B ^a   Gilmore, John H ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

D1 Receptors; Dopamine; Human development; SCH23390; Schizophrenia

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT;

ADOLESCENT; ADULT; ARTICLE; AUTORADIOGRAPHY; CAUDATE NUCLEUS; CHILD; DEVELOPMENT; DOPAMINERGIC SYSTEM; DRUG RECEPTOR BINDING; HUMAN; HUMAN TISSUE; MATURATION; NORMAL HUMAN; PRIORITY JOURNAL; PUTAMEN; RECEPTOR AFFINITY; RECEPTOR DENSITY; SCHIZOPHRENIA;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ADOLESCENT; ADULT; AGE FACTORS; AUTORADIOGRAPHY; BINDING SITES; CAUDATE NUCLEUS; DOPAMINE ANTAGONISTS; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; PUTAMEN; RADIOLIGAND ASSAY; RECEPTORS, DOPAMINE D1; SCHIZOPHRENIA;

EID: 0032874775     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(99)00062-7     Document Type: Article

References (56)

1. Angrist B.M., Gershon S. The phenomenology of experimentally induced amphetamine psychosis-preliminary observation. Biol Psychiatry. 2:1970;95-107.
2. Bannon M.J., Poosch M.S., Xia Y., Goebel D.J., Cassin B., Kapatos G. Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age. Proc Natl Acad Sci USA. 89:1992;7095-7099.
3. Benes F.M., McSparren J., Bird E.D., SanGiovanni J.P., Vincent S.L. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry. 48:1991;996-1022.
4. 5 dopamine receptor. Studies in primate brain and transfected mammalian cells Proc Natl Acad Sci USA. 92:1995;3468-3472. a.
5. 5 dopamine receptors in primate brain. J Neurosci. 15:1995;7821-7836. b.
6. 2 dopamine receptors in perinatal and adult basal ganglia. Ped Res. 41:1997;822-831.
7. 2 receptors, adenylate cyclase regulation and presynaptic dopamine markers. Dev Brain Res. 52:1990;265-271.
8. Carlsson M., Carlsson A. Schizophrenia. A subcortical neurotransmitter imbalance syndrome? Schizophr Bull. 16:1990;425-432.
9. Chua S.E., McKenna P.J. Schizophrenia - a brain disease? A critical review of structural and functional cerebral abnormality in the disorder. Br J Psychiatry. 166:1995;563-582.
10. 5 receptor mRNAs in the monkey brain. Ribonuclease protection assay analysis Brain Res Mol Brain Res. 31:1995;86-94.
11. Creese I., Burt D.R., Snyder S.H. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science. 192:1976;480-483.
12. 1 dopamine receptors in the rat brain. A quantitative autoradiographic analysis J Neurosci. 6:1986;2352-2365.
13. Davis K.L., Kahn R.S., Ko G., Davidson M. Dopamine in schizophrenia. A review and reconceptualization Am J Psychiatry. 148:1991;1474-1486.
14. De Keyser J., Ebinger G., Vauquelin G. Age-related changes in the human nigrostriatal dopaminergic system. Ann Neurol. 27:1990;157-161.
15. Feinberg I. Schizophrenia. Caused by a fault in programmed synaptic elimination during adolescence? J Psychiatric Res. 17:1982;319-334.
16. Fenton W.S., McGlashan T.H. Natural history of schizophrenia subtypes. I. Longitudinal study of paranoid, hebephrenic, and undifferentiated schizophrenia Arch Gen Psychiatry. 48:1991;969-977.
17. 2 receptor sites in rat striatum. Dev Brain Res. 49:1989;123-130.
18. Gerfen C.R. The neostriatal mosaic. Multiple levels of compartmental organization TINS. 15:1992;133-139.
19. Gerfen C.R. Dopamine receptor function in the basal ganglia. Clin Neuropharmacol. 18:1995;S162-S177.
20. 1 receptors. Mol Brain Res. 18:1993;290-296.
21. Grace A.A. Phasic versus tonic dopamine release and the modulation of dopamine system responsitivity. A hypothesis for the etiology of schizophrenia Neuroscience. 41:1991;1-24.
22. Graybiel A. The basal ganglia and cognitive pattern generators. Schizophr Bull. 23:1997;459-469.
23. Harrison P.J. Schizophrenia. A disorder of neurodevelopment? Curr Opin Neurobiol. 7:1997;285-289. a.
24. Harrison P.J. Schizophrenia and its dementia. Esin M.M., Morris J.H. The Neuropathology of Dementia. 1997;383-395 Cambridge University Press, Cambridge, UK. b.
25. Henry J.M., Filburn C.R., Joseph J.A., Roth G.S. Effect of aging on striatal dopamine receptor subtypes in Wistar rats. Neurobiol Aging. 7:1986;357-361.
26. Keshavan M.S., Anderson S., Pettegrew J.W. Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. J Psychiatry Res. 28:1994;239-265.
27. Kotrola K.J., Weinberger D.R. Brain imaging in schizophrenia. Ann Rev Med. 46:1995;113-122.
28. Laruelle M., Abi-Dargham A., van Dyck C.H., Gil R., D'Souza C.D., Erdos J., McCance E., Rosenblatt W., Fingado C., Zoghbi S.S., Baldwin R.M., Seibyl J.P., Krystal J.H., Charney D.S., Innis R.B. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci USA. 93:1996;9235-9240.
29. Leckman J.F., Peterson B.S., Anderson G.M., Arnsten A.F., Pauls D.L., Cohen D.J. Pathogenesis of Tourette's syndrome. J Child Psychol Psychiatry Allied Discipl. 38:1997;119-142.
30. 2 dopaminergic receptors in the developing cerebral cortex of macaque monkey. A film autoradiographic study Neuroscience. 65:1995;439-452.
31. Lidow M.S., Goldman-Rakic P.S., Rakic P. Synchronized overproduction of neurotransmitter receptors in diverse regions of the primate cerebral cortex. Proc Natl Acad Sci USA. 88:1991;10218-10221.
32. Lidow M.S., Rakic P. Scheduling of monoaminergic neurotransmitter receptor expression in the primate neocortex during postnatal development. Cereb Cortex. 2:1992;401-416.
33. Lidow M.S., Wang F., Cao Y., Goldman-Rakic P.S. Layer V neurons bear the majority of mRNAs encoding the five distinct dopamine receptor subtypes in the primate prefrontal cortex. Synapse. 28:1998;10-20.
34. Lieberman J.A., Sheitman B.B., Kinon B.J. Neurochemical sensitization in the pathophysiology of schizophrenia. Deficits and dysfunction in neuronal regulation and plasticity Neuropsychopharmacology. 17:1997;205-229.
35. Meltzer H.Y., Stahl S.M. The dopamine hypothesis of schizophrenia. A review Schizophr Bull. 2:1976;19-76.
36. Pakkenberg B. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch Gen Psychiatry. 47:1990;1023-1028.
37. Palacios J.M., Camps M., Cortes R., Probst A. Mapping dopamine receptors in the human brain. J Neural Transm. 27(suppl):1988;227-235.
38. Palmer A.M., DeKosky S.T. Monoamine neurons in aging and Alzheimer's disease. J Neural Transm. 91:1993;135-159.
39. Pfefferbaum A., Marsh L. Structural brain imaging in schizophrenia. Clin Neurosci. 3:1995;105-111.
40. 2 receptor binding characteristics in vivo. Am J Psychiatry. 155:1998;768-773.
41. Rakic P., Bourgeois J.-P., Eckenhoff M.F., Zecevic N., Goldman-Rakic P.S. Concurrent overproduction of synapses in diverse regions of the primate cerebral cortex. Science. 232:1986;232-235.
42. 1-like receptors in the rat cerebellar cortex. Synapse. 21:1995;37-44.
43. Rinne J.O. Muscarinic and dopaminergic receptors in the aging human brain. Brain Res. 404:1987;162-168.
44. 2 receptors. Brain Res. 508:1990;349-352.
45. 2 dopamine receptor subtypes in rat brain using in situ hybridization and receptor binding. Neuroscience. 62:1994;65-85.
46. Seeman P. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse. 1:1987;133-152.
47. Seeman P., Bzowej N.H., Guan H.-C., Bergeron C., Becker L.E., Reynolds G.P., Bird E.D., Riederer P., Jellinger K., Watanabe S., Tourtellotte W.W. Human brain dopamine receptors in children and aging adults. Synapse. 1:1987;399-404.
48. 1. Nature. 350:1991;614-619.
49. Teicher M.H., Andersen S.L., Hostetter J.C. Evidence for dopamine receptor pruning between adolescence and adulthood in striatum but not nucleus accumbens. Dev Brain Res. 89:1995;167-172.
50. Walker E., Neumann C. Neurodevelopmental origins of schizophrenia. NASRAD Res Lett Spring: 14-16:1994.
51. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry. 44:1987;660-669.
52. Weinberger D.R. From neuropathology to neurodevelopment. Lancet. 346:1995;552-557.
53. 1 beta) and its pseudogene. J Biol Chem. 266:1991;22427-22435.
54. Wolf S.S., Weinberger D.R. Schizophrenia. A new frontier in developmental neurobiology Israel J Med Sci. 32:1996;51-55.
55. Wyrick S.D., Mailman R.B. Tritium labeled (()-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SCH23390). J Label Compd Radiopharm. 22(2):1985;189-195.
56. 1 receptor mRNA-containing neurons. Neurobiol Aging. 18:1997;251-255.